Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in NXTC — NextCure, Inc.

CIK 1166588 NEW YORK, NY
Back to NXTC Full portfolio

Position in NXTC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$51
-$290 QoQ
Shares Held
32
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. NXTC ranks #391 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in NXTC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51 32
2026-03-31 $341 32
2025-12-31 $454 32
2025-09-30 $187 32
2025-06-30 $177 385
2025-03-31 $184 385
2024-12-31 $296 385
2024-09-30 $527 385
2024-06-30 $612 385
2024-03-31 $858 385
2023-12-31 $438 385
2023-09-30 $496 385
2023-06-30 $692 385
2023-03-31 $569 385
2022-12-31 $779 553
2022-09-30 $1,058 385
2022-06-30 $3,642 775
2022-03-31 $1,871 385
2021-12-31 $2,309 385
2021-09-30 $2,594 385
2021-06-30 $16,911 2,106
2021-03-31 $28,328 2,830
2020-12-31 $46,717 4,286
2020-09-30 $32,375 3,679
2020-06-30 $13,164 614
2020-03-31 $228,833 6,173